AU Stock MarketDetailed Quotes

NSB Neuroscientific Biopharmaceuticals Ltd

Watchlist
  • 0.038
  • -0.001-2.56%
20min DelayTrading Jul 3 14:31 AET
5.49MMarket Cap-5428P/E (Static)

Neuroscientific Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(FY)Jun 30, 2021
(Q4)Jun 30, 2021
(FY)Jun 30, 2020
(Q4)Jun 30, 2020
(FY)Jun 30, 2019
(Q4)Jun 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments
-31.93%4.91M
-31.93%4.91M
-49.05%7.22M
-49.05%7.22M
330.88%14.16M
330.88%14.16M
-28.70%3.29M
-28.70%3.29M
--4.61M
--4.61M
-Cash and cash equivalents
-31.93%4.91M
-31.93%4.91M
-49.05%7.22M
-49.05%7.22M
330.88%14.16M
330.88%14.16M
-28.70%3.29M
-28.70%3.29M
--4.61M
--4.61M
-Accounts receivable
-64.06%43.47K
-64.06%43.47K
144.82%120.93K
144.82%120.93K
158.18%49.4K
158.18%49.4K
-30.87%19.13K
-30.87%19.13K
--27.68K
--27.68K
Total current assets
-32.28%5.01M
-32.28%5.01M
-48.72%7.4M
-48.72%7.4M
336.40%14.43M
336.40%14.43M
-28.71%3.31M
-28.71%3.31M
--4.64M
--4.64M
Non current assets
-Goodwill
-15.48%272.5K
-15.48%272.5K
-13.41%322.42K
-13.41%322.42K
-11.83%372.35K
-11.83%372.35K
-10.57%422.29K
-10.57%422.29K
--472.21K
--472.21K
Regulatory assets
-64.06%43.47K
-64.06%43.47K
144.82%120.93K
144.82%120.93K
158.18%49.4K
158.18%49.4K
-30.87%19.13K
-30.87%19.13K
--27.68K
--27.68K
Liabilities
Current liabilities
-accounts payable
-72.97%585.5K
-72.97%585.5K
1,132.50%2.17M
1,132.50%2.17M
185.36%175.74K
185.36%175.74K
42.69%61.59K
42.69%61.59K
--43.16K
--43.16K
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Current liabilities
-73.06%597.36K
-73.06%597.36K
892.65%2.22M
892.65%2.22M
152.35%223.41K
152.35%223.41K
41.70%88.53K
41.70%88.53K
--62.48K
--62.48K
Non current liabilities
Non current accrued expenses
-47.42%8.79K
-47.42%8.79K
-39.95%16.72K
-39.95%16.72K
195.10%27.84K
195.10%27.84K
-31.60%9.44K
-31.60%9.44K
--13.79K
--13.79K
Preferred securities outside stock equity
-77.06%11.86K
-77.06%11.86K
8.44%51.7K
8.44%51.7K
76.90%47.67K
76.90%47.67K
39.50%26.95K
39.50%26.95K
--19.32K
--19.32K
Total non current liabilities
-73.06%597.36K
-73.06%597.36K
892.65%2.22M
892.65%2.22M
152.35%223.41K
152.35%223.41K
41.70%88.53K
41.70%88.53K
--62.48K
--62.48K
Shareholders'equity
Share capital
0.00%25.27M
0.00%25.27M
0.00%25.27M
0.00%25.27M
115.74%25.27M
115.74%25.27M
9.42%11.72M
9.42%11.72M
--10.71M
--10.71M
-common stock
0.00%25.27M
0.00%25.27M
0.00%25.27M
0.00%25.27M
115.74%25.27M
115.74%25.27M
9.42%11.72M
9.42%11.72M
--10.71M
--10.71M
Gains losses not affecting retained earnings
-15.32%2.41M
-15.32%2.41M
88.92%2.84M
88.92%2.84M
38.85%1.5M
38.85%1.5M
70.47%1.08M
70.47%1.08M
--635.75K
--635.75K
Total equity
-31.62%5.29M
-31.62%5.29M
-47.82%7.74M
-47.82%7.74M
296.70%14.83M
296.70%14.83M
-27.05%3.74M
-27.05%3.74M
--5.12M
--5.12M
(FY)Jun 30, 2023(Q4)Jun 30, 2023(FY)Jun 30, 2022(Q4)Jun 30, 2022(FY)Jun 30, 2021(Q4)Jun 30, 2021(FY)Jun 30, 2020(Q4)Jun 30, 2020(FY)Jun 30, 2019(Q4)Jun 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments -31.93%4.91M-31.93%4.91M-49.05%7.22M-49.05%7.22M330.88%14.16M330.88%14.16M-28.70%3.29M-28.70%3.29M--4.61M--4.61M
-Cash and cash equivalents -31.93%4.91M-31.93%4.91M-49.05%7.22M-49.05%7.22M330.88%14.16M330.88%14.16M-28.70%3.29M-28.70%3.29M--4.61M--4.61M
-Accounts receivable -64.06%43.47K-64.06%43.47K144.82%120.93K144.82%120.93K158.18%49.4K158.18%49.4K-30.87%19.13K-30.87%19.13K--27.68K--27.68K
Total current assets -32.28%5.01M-32.28%5.01M-48.72%7.4M-48.72%7.4M336.40%14.43M336.40%14.43M-28.71%3.31M-28.71%3.31M--4.64M--4.64M
Non current assets
-Goodwill -15.48%272.5K-15.48%272.5K-13.41%322.42K-13.41%322.42K-11.83%372.35K-11.83%372.35K-10.57%422.29K-10.57%422.29K--472.21K--472.21K
Regulatory assets -64.06%43.47K-64.06%43.47K144.82%120.93K144.82%120.93K158.18%49.4K158.18%49.4K-30.87%19.13K-30.87%19.13K--27.68K--27.68K
Liabilities
Current liabilities
-accounts payable -72.97%585.5K-72.97%585.5K1,132.50%2.17M1,132.50%2.17M185.36%175.74K185.36%175.74K42.69%61.59K42.69%61.59K--43.16K--43.16K
-Total tax payable --0--0--0--0--0--0--0--0--0--0
Current liabilities -73.06%597.36K-73.06%597.36K892.65%2.22M892.65%2.22M152.35%223.41K152.35%223.41K41.70%88.53K41.70%88.53K--62.48K--62.48K
Non current liabilities
Non current accrued expenses -47.42%8.79K-47.42%8.79K-39.95%16.72K-39.95%16.72K195.10%27.84K195.10%27.84K-31.60%9.44K-31.60%9.44K--13.79K--13.79K
Preferred securities outside stock equity -77.06%11.86K-77.06%11.86K8.44%51.7K8.44%51.7K76.90%47.67K76.90%47.67K39.50%26.95K39.50%26.95K--19.32K--19.32K
Total non current liabilities -73.06%597.36K-73.06%597.36K892.65%2.22M892.65%2.22M152.35%223.41K152.35%223.41K41.70%88.53K41.70%88.53K--62.48K--62.48K
Shareholders'equity
Share capital 0.00%25.27M0.00%25.27M0.00%25.27M0.00%25.27M115.74%25.27M115.74%25.27M9.42%11.72M9.42%11.72M--10.71M--10.71M
-common stock 0.00%25.27M0.00%25.27M0.00%25.27M0.00%25.27M115.74%25.27M115.74%25.27M9.42%11.72M9.42%11.72M--10.71M--10.71M
Gains losses not affecting retained earnings -15.32%2.41M-15.32%2.41M88.92%2.84M88.92%2.84M38.85%1.5M38.85%1.5M70.47%1.08M70.47%1.08M--635.75K--635.75K
Total equity -31.62%5.29M-31.62%5.29M-47.82%7.74M-47.82%7.74M296.70%14.83M296.70%14.83M-27.05%3.74M-27.05%3.74M--5.12M--5.12M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg